Literature DB >> 1880405

On the clinical importance of Dientamoeba fragilis infections in childhood.

U Preiss1, G Ockert, S Broemme, A Otto.   

Abstract

Clinical and laboratory findings among 123 paediatric patients infected by intestinal protozoa were analysed. Dientamoeba fragilis (D. f) was found in 102 cases. The other patients proved to be carriers of Giardia lamblia or of mixed infections with several protozoa. Acute and recurrent diarrhoea have been found to be the most common symptoms, whereas abdominal pain was most common in children with chronic infections. Peripheral blood eosinophilia was seen in a third of the children with dientamoebiasis. Metronidazole, oxytetracycline, doxycycline, and erythromycin were effective drugs in the treatment of D. f. infections. The therapy coincidentally led to the elimination of protozoal infections as well as the abdominal complaints. These results underline the pathogenic role of D. f. in children with gastrointestinal symptoms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880405

Source DB:  PubMed          Journal:  J Hyg Epidemiol Microbiol Immunol        ISSN: 0022-1732


  15 in total

1.  Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens.

Authors:  D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 2.  Does Dientamoeba fragilis cause diarrhea? A systematic review.

Authors:  Zing-Wae Wong; Kate Faulder; Joan L Robinson
Journal:  Parasitol Res       Date:  2018-02-05       Impact factor: 2.289

Review 3.  Dientamoeba fragilis, One of the Neglected Intestinal Protozoa.

Authors:  Lynne S Garcia
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

4.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

5.  Cryptic genetic diversity in Dientamoeba fragilis.

Authors:  J A Johnson; C G Clark
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population.

Authors:  D Stark; N Beebe; D Marriott; J Ellis; J Harkness
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Comparison and Recommendations for Use of Dientamoeba fragilis Real-Time PCR Assays.

Authors:  Rory Gough; John Ellis; Damien Stark
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

Review 8.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

9.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

Review 10.  Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis.

Authors:  Eugene H Johnson; Jeffrey J Windsor; C Graham Clark
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.